Fragile antibiotic supply leads to shortages worldwide
READ MORE
Shortages of some life-saving antibiotics are putting growing numbers of patients at risk and fuelling the evolution of “superbugs” that do not respond to modern medicines, according to a new report.
The non-profit Access to Medicine Foundation (AMF) said Thursday there was an emerging crisis in the global anti-infectives market as fragile drug supply chains — reliant on just a few big suppliers — come close to collapse.
The result is shortages of products like piperacillin-tazobactam, an antibiotic combination used intravenously in intensive care, which has been in tight supply since a 2016 explosion at a Chinese pharmaceutical ingredients factory.
Another antibiotic, benzathine penicillin G (BPG), faces shortages in at least 39 countries, including Germany and Brazil.
BPG is a key drug for preventing transmission of syphilis from mother to child and the shortage frustrated Brazil’s efforts to bring a disease outbreak under control between 2012 and 2015. BPG is also used to fight rheumatic heart disease.
‘Things are getting worse’
In absence of the right drugs, patients may take less effective or poor quality medicines that increase the risk of antimicrobial resistance developing.
“Things are getting worse because the market is not fixing the problem, despite the expansion in the need for such specialist antibiotics,” said AMF Executive Director Jayasree Iyer.
Article source: https://www.thelocal.fr/20170921/yes-you-can-live-in-paris-without-speaking-french
Comments
Post a Comment